» Articles » PMID: 7061686

Evidence for Dopaminergic Control of Circadian Variations in Thyrotropin Secretion

Overview
Specialty Endocrinology
Date 1982 Apr 1
PMID 7061686
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

This study examines the influence of dopamine of recumbent circadian secretory patterns of plasma TSH. Seven euthyroid men were studied during a control (no medication) and a bromocriptine period (2.5 mg bromocriptine three times a day for 5 days). In the control period, a clear daily pattern in plasma TSH was evidenced, with highest levels occurring during the late evening presleep period and the fist few hours after the onset of nocturnal sleep. During the control period, recumbent 24-h plasma TSH was linearly correlated (gamma = 0.41; P less than 0.05) with clock time. Bromocriptine lowered the mean 24-h TSH from a control level of 2.1 +/- 0.2 to 1.1 microunits/ml. Further, bromocriptine eliminated the early nocturnal TSH surge and the correlation of plasma TSH with clock time. Thus, circadian variations in plasma TSH levels may be modulated, in part, by a dopaminergic mechanism. However, we cannot rule out a direct effect of bromocriptine on the anterior pituitary resulting in decreased late evening rises in plasma TSH.

Citing Articles

Pulsatile secretion of thyrotropin in children.

Loche S, Cherubini V, Bartolotta E, Lampis A, Carta D, Tomasi P J Endocrinol Invest. 1994; 17(3):189-93.

PMID: 8051341 DOI: 10.1007/BF03347715.


Recovery of serum TSH and thyroid hormones after 3'isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels.

Burger A J Endocrinol Invest. 1984; 7(5):501-5.

PMID: 6439772 DOI: 10.1007/BF03348457.


TRH: pathophysiologic and clinical implications.

Pickardt C, Scriba P Acta Neurochir (Wien). 1985; 75(1-4):43-8.

PMID: 3922203 DOI: 10.1007/BF01406322.


Multifactorial control of the 24-hour secretory profiles of pituitary hormones.

Van Cauter E, Refetoff S J Endocrinol Invest. 1985; 8(4):381-91.

PMID: 2999212 DOI: 10.1007/BF03348519.